FDA to publish study on potential adverse COVID vaccine events in elderly: report

 Researchers at the U.S. Food and Drug Administration (FDA) are planning on publishing a study on four potential adverse effects in elderly people who received the Pfizer/BioNTech COVID-19 vaccine. The study results are currently under internal review at FDA and are expected later this fall

The FDA in 2021 identified four potential adverse events - blood clots in lungs, low blood platelet levels, insufficient oxygen to the heart and disseminated intravascular coagulation - after analyzing Medicare insurance plan claims.

• These four events may not be true safety concerns, and the screening method cannot establish that the vaccine caused these [adverse events of interest].

https://justthenews.com/politics-policy/coronavirus/fda-publish-study-potential-adverse-covid-vaccine-events-elderly-report